PERRIGO PLC (PRGO)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for PRGO
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PRGO | Director; Executive Vice President & Chief Financial Officer | ["Executive", "Executive Vice President & Chief Financial Officer at Allogene Therapeutics, Inc.", "Chief Operating Officer & Chief Financial Officer at Tricida, Inc.", "Chief Financial Officer at Anacor Pharmaceuticals, Inc.", "Managing Director and Partner, Healthcare Investment Banking at Goldman Sachs", "Expertise in healthcare sector and senior executive experience", "Unique understanding of trends in the healthcare industry", "Experience with emerging technologies and regulatory strategies", "Valuable perspective on financial management and capital allocation", "Extensive capital markets and M&A experience"] | [] | 2026 |
Biography sourced from the proxy statement filing.
2023 Present: Executive Vice President & Chief Financial Officer, Allogene Therapeutics, Inc, a biotechnology company 2017 2023: Chief Operating Officer & Chief Financial Officer, Tricida, Inc, a biotechnology company 2010 2015: Chief Financial Officer, Anacor Pharmaceuticals, Inc., a biotechnology company 1997 2009: Managing Director and Partner, Healthcare Investment Banking, Goldman Sachs, a multinational investment bank and financial service company Other Public Company Directorships 2021 March 2024: Better Therapeutics (NASDAQ: BTTX) 2009 2022: ChemoCentryx (NASDAQ: CCXI) 2016 2019: Genomic Health (NASDAQ: GHDX) 2016 2017: Sunesis Pharmaceuticals (NASDAQ: SNSS) Notable Experience and Key Skill Sets Mr. Parker has developed expertise across the healthcare sector through his extensive experience as a senior executive at multiple biotechnology companies, as a board member at multiple healthcare companies and as an investment banker to the healthcare industry. He brings a unique understanding of trends in the healthcare industry including experience with emerging technologies and regulatory strategies. Mr. Parker also provides valuable perspective on areas of financial management and capital allocation. He has extensive capital markets and M&A experience as an experienced chief financial officer across three companies and over twenty years as an investment banker.